Off-label closure during CLOSURE study

Journal of Invasive Cardiology

Volumn 24, Issue 11, 2012, Pages 608-611

  Stackhouse, Kathryn A ^a   Goel, Sachin S ^b   Qureshi, Athar M ^b   Prieto, Lourdes ^b   Kapadia, Samir ^b   Tuzcu, E Murat ^b   Krasuski, Richard A ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

off label closures; patent foramen ovale

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIAC EQUIPMENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEVICE THERAPY; DISEASE SEVERITY; FEMALE; HEART RIGHT LEFT SHUNT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OFF LABEL THERAPY; PATENT FORAMEN OVALE; PROSPECTIVE STUDY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; CARDIAC CATHETERIZATION; FORAMEN OVALE, PATENT; HEMATOLOGIC AGENTS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; OFF-LABEL USE; PROSPECTIVE STUDIES; PROSTHESIS IMPLANTATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 84869399833     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kerut EK, Norfeet W T, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol. 2001;38(3):613-623.
2. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000;55(8):1172-1179.
3. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the frst 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17-20. (Pubitemid 14175830)
4. Aggarwal K, Jayam VK, Meyer MA, Nayak AK, Nathan S. Thrombus-in-transit and paradoxical embolism. J Am Soc Echocardiogr. 2002;15(9):1021-1022.
5. Koullias GJ, Elefteriades JA, Wu I, Jovin I, Jadbabaie F, McNamara R. Images in cardiovascular medicine. Massive paradoxical embolism: caught in the act. Circulation. 2004;109(24):3056-3057. (Pubitemid 38808329)
6. Nellessen U, Daniel WG, Matheis G, Oelert H, Depping K, Lichtlen PR. Impending paradoxical embolism from atrial thrombus: correct diagnosis by transesophageal echocar-diography and prevention by surgery. J Am Coll Cardiol. 1985;5(4):1002-1004. (Pubitemid 15110158)
7. Srivastava TN, Payment M F. Images in clinical medicine. Paradoxical embolism\thrombus in transit through a patent foramen ovale. N Engl J Med. 1997;337(10):681.
8. Lethen H, Flachskampf FA, Schneider R, et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol. 1997;80(8):1066-1069.
9. Mono M-L, Geister L, Galimanis A, et al. Patent foramen ovale may be causal for the frst stroke but unrelated to subsequent ischemic events. Stroke. 2011;42(10):2891-2895.
10. Stollberger C, Slany J, Schuster I, Leitner H, Winkler WB, Karnik R. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med. 1993;119(6):461-465. (Pubitemid 23310106)
11. Kapadia SR. Patent foramen ovale closure: historical perspective. Cardiol Clin. 2005;23(1):73-83.
12. Krasuski RA. When and how to fx a "hole in the heart": approach to ASD and PFO. Cleve Clin J Med. 2007;74(2):137-147.
13. Opotowsky AR, Landzberg MJ, Kimmel SE, Webb GD. Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004. JAMA. 2008;299(5):521-522. (Pubitemid 351214263)
14. Khairy P, O'Donnell C P, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med. 2003;139(9):753-760.
15. Agarwal S, Bajaj NS, Kimbhani DJ, Tuzcu EM, Kapadia SR. Meta-analysis of trans-catheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism. JACC Cardiovasc Interv. 2012;5(7):777-789.
16. Wahl A, Juni P, Mono M-L, et al. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation. 2012;125(6):803-812.
17. Furlan AJ, Reisman M, Massaro J, et al. Study design of the CLOSURE I trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and effcacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Stroke. 2010;41(12):2872-2883.
18. Goel SS, Tuzcu EM, Shishehbor MH, et al. Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. Am J Cardiol. 2009;103(1):124-129.
19. Franke A, Hanrath P. The role of atrial septal abnormalities in cryptogenic stroke\still questionable? Eur Heart J. 2001;22(3):198-200. (Pubitemid 32622469)
20. Furlan AJ, Reisman M, Massaro J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991- 999.
21. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007;357(22):2262-2268. (Pubitemid 350190756)
22. Fukuoka T, Dembo T, Nagoya H, et al. Factors related to recurrence of paradoxical cerebral embolism due to patent foramen ovale. J Neurol. 2012;259(6):1051-1055.